All In Biotech

Free tool

FAERS Monitor: Dysport

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125274 or its brand name (Dysport, Abobotulinumtoxina). Reports on generic versions are filed under their own applications.

Reports

12,740

Serious

7,124

56% of reports

Hospitalization

2,912

Death reported

1,978

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use4,935
  • drug ineffective3,728
  • headache1,650
  • drug intolerance1,376
  • product use in unapproved indication1,364
  • nausea1,328
  • migraine1,209
  • dizziness1,180
  • pain1,176
  • hypoaesthesia1,160
  • fatigue1,113
  • asthenia1,089
  • muscular weakness1,053
  • paraesthesia984
  • maternal exposure during pregnancy983

Reports by year received

View as table
YearReports
20047
20057
200610
200735
200869
200987
2010147
2011179
2012642
201375
201469
201585
2016127
2017876
20181,118
2019631
2020563
2021967
20221,272
20231,463
20241,561
20251,713
20261,037

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,419 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug intoleranceSignal1,37623.822.729,797
migraineSignal1,20921.220.123,017
maternal exposure during pregnancySignal98318.417.316,048
muscular weaknessSignal1,05315.414.614,139
hypoaesthesiaSignal1,16012.912.212,698
paraesthesiaSignal98410.49.88,346
off label useSignal4,9359.49.138,182
product use in unapproved indicationSignal1,3649.18.79,930
astheniaSignal1,0894.84.53,314
drug ineffectiveSignal3,7284.74.611,474
headacheSignal1,6504.44.24,379
dizzinessSignal1,1803.93.72,612
painSignal1,1763.23.01,788
nauseaSignal1,3282.82.61,560
fatigueSignal1,1132.42.2905

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.